“Yeah, I guess I would say for R&D specifically, I think at…” — Maryland CC Project at 37:43
“Yeah, I guess I would say for R&D specifically, I think at the threshold, there's relatively low risk for a moral time. We did run into, I think, heterogeneity of treatment effect or worries, but concern for heterogeneity of treatment effect with time. And when we initially submitted this, our primary analysis was a…”
0:00
42:10